Even the CEOs of Big Pharmas have come under fire. Activist investor Starboard Value has made no secret of its criticism of Pfizer CEO Albert Bourla’s track record, while GSK CEO Emma Walmsley fought ...

The week has started with reports that activist investor Starboard Value has amassed a $1 billion stake in pharma group Pfizer and wants strategic changes to restore growth.

Starboard Value on Wednesday nominated three director candidates, including its chief executive and founder, Jeff Smith, to Autodesk's 13-member board, rekindling its proxy battle with the ...

As of the close of business on March 25, 2025, 247,455 shares of Common Stock were held in an account managed by Starboard Value LP (the “Starboard Value LP Account”).

Hedge Fund Market To Skyrocket To $13 Trillion Globally By 2032, Growing At A Steady 10.7% CAGR As Revealed In New Report (WhaTech.com ...

Pharmalittle: We’re reading about RFK Jr. being open to seizing drug patents, pharma raising prices, and more Sage Therapeutics rejected a $469 million offer from Biogen, saying it undervalues ...

Citing Wall Street Research estimates, Starboard argued that the pharma will miss its 2030 M&A sales target by $7 billion. The GBT acquisition was particularly problematic for Starboard, which flagged ...

Pfizer Inc. got a reprieve — at least for now — in its battle with activist investor Starboard Value LP, according to people familiar with the matter. Starboard did not nominate any directors to ...

Pfizer Inc. got a reprieve — at least for now — in its battle with activist investor Starboard Value LP, according to people familiar with the matter.

Riot Platforms stock jumped on Thursday on news that Starboard Value, the activist investor that took a stake in Pfizer earlier this year, has amassed a significant position in the bitcoin miner.

Amidst dwindling share prices and widespread criticism, Pfizer CEO Albert Bourla appears to have withstood an attempted ousting by activist investor Starboard Value. On 6 October, Bourla received a ...

Starboard has taken a total of 152 prior activist campaigns in its history and has an average return of 25.02% versus 13.65% for the Russell 2000 over the same period.